Publications

Recent Publications

2024

Laws A, Leonard S, Hershey E, Stokes S, Vincuilla J, Sharma E, Milliron K, Garber JE, Merajver SD, King TA, Pilewskie ML. ASO Visual Abstract: Upgrade Rates and Breast Cancer Development Among Germline Pathogenic Variant Carriers with High-Risk Breast Lesions. Ann Surg Oncol. 2024 Feb 16. doi: 10.1245/s10434-024-15067-5. Epub ahead of print. PMID: 38366181. 

Laws A, Leonard S, Hershey E, Stokes S, Vincuilla J, Sharma E, Milliron K, Garber JE, Merajver SD, King TA, Pilewskie ML. Upgrade Rates and Breast Cancer Development Among Germline Pathogenic Variant Carriers with High-Risk Breast Lesions. Ann Surg Oncol. 2024 Jan 23. doi: 10.1245/s10434-024-14947-0. Epub ahead of print. PMID: 38261128.

Mao W, Vandecan NM, Bingham CR, Tsang PK, Ulintz P, Sexton R, Bochar DA, Merajver SD, Soellner MB. Selective and Potent PROTAC Degraders of c-Src Kinase. ACS Chem Biol. 2024 Jan 19;19(1):110-116. doi: 10.1021/acschembio.3c00548. Epub 2023 Dec 19. PMID: 38113191.  

Liu Y, Joy ST, Henley MJ, Croskey A, Yates JA, Merajver SD, Mapp AK. Inhibition of CREB Binding and Function with a Dual-Targeting Ligand. Biochemistry. 2023 Dec 12. doi: 10.1021/acs.biochem.3c00469. Epub ahead of print. PMID: 38086054. 

2023

Daly MB, Pal T, Maxwell KN, Churpek J, Kohlmann W, AlHilli Z, Arun B, Buys SS, Cheng H, Domchek SM, Friedman S, Giri V, Goggins M, Hagemann A, Hendrix A, 

Hutton ML, Karlan BY, Kassem N, Khan S, Khoury K, Kurian AW, Laronga C, Mak JS, Mansour J, McDonnell K, Menendez CS, Merajver SD, Norquist BS, Offit K, 

Rash D, Reiser G, Senter-Jamieson L, Shannon KM, Visvanathan K, Welborn J, Wick MJ, Wood M, Yurgelun MB, Dwyer MA, Darlow SD. NCCN Guidelines® 

Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024. J Natl Compr Canc Netw. 2023 Oct;21(10):1000-1010. doi:

10.6004/jnccn.2023.0051. PMID: 37856201.

Pleasant VA, Purkiss AS, Merjaver SD. Redefining the "crown": Approaching chemotherapy-induced alopecia among Black patients with breast cancer. Cancer. 2023 Jun 1;129(11):1629-1633. doi: 10.1002/cncr.34732. Epub 2023 Mar 30. PMID: 37158640.

Morikawa A, Li J, Ulintz P, Cheng X, Apfel A, Robinson D, Hopkins A, Kumar-Sinha C, Wu YM, Serhan H, Verbal K, Thomas D, Hayes DF, Chinnaiyan AM, Baladandayuthapani V, Heth J, Soellner MB, Merajver SD, Merrill N. Optimizing Precision Medicine for Breast Cancer Brain Metastases with Functional Drug Response Assessment. Cancer Res Commun. 2023 Jun 21;3(6):1093-1103. doi: 10.1158/2767-9764.CRC-22-0492. PMID: 37377606; PMCID: PMC10284082. 

Westerhof TM, Yang BA, Merill NM, Yates JA, Altemus M, Russell L, Miller AJ, Bao L, Wu Z, Ulintz PJ, Aguilar CA, Morikawa A, Castro MG, Merajver SD, Oliver CR. Blood-brain barrier remodeling in an organ-on-a-chip device shows Dkk1 to be a regulator of early metastasis. Adv Nanobiomed Res. 2023 Apr;3(4):2200036. doi: 10.1002/anbr.202200036. Epub 2023 Feb 5. PMID: 37234365; PMCID: PMC10208594. 

Pattelli ON, Valdivia EM, Beyersdorf MS, Regan CS, Rivas M, Merajver SD, Cierpicki T, Mapp AK. A lipopeptidomimetic of transcriptional activation domains selectively disrupts Med25 PPIs. bioRxiv [Preprint]. 2023 Mar 25:2023.03.24.534168. doi: 10.1101/2023.03.24.534168. PMID: 36993479; PMCID: PMC10055422. 

Fleege NMG, Pierce-Gjeldum D, Swartz LK, Verbal K, Merajver S, Friese CR, Kiyota A, Heth J, Leung D, Smith SR, Gabel N, Kim MM, Morikawa A. IMPACT the Brain: A Team-Based Approach to Management of Metastatic Breast Cancer With CNS Metastases. JCO Oncol Pract. 2023 Jan;19(1):e67-e77. doi: 10.1200/OP.22.00291. Epub 2022 Oct 12. PMID: 36223556; PMCID: PMC9870235. 

2022

Achreja A, Yu T, Mittal A, Choppara S, Animasahun O, Nenwani M, Wuchu F, Meurs N, Mohan A, Jeon JH, Sarangi I, Jayaraman A, Owen S, Kulkarni R, Cusato M, Weinberg F, Kweon HK, Subramanian C, Wicha MS, Merajver SD, Nagrath S, Cho KR, DiFeo A, Lu X, Nagrath D. Metabolic collateral lethal target identification reveals MTHFD2 paralogue dependency in ovarian cancer. Nat Metab. 2022 Sep;4(9):1119-1137. doi: 10.1038/s42255-022-00636-3. Epub 2022 Sep 21. PMID: 36131208.

Abusamra SM, Solorzano MA, Luke M, Quarles J, Jacobs MF, Das S, Kasputis A, Okoth LA, Patel M, Seymore M, Caram MEV, Dunn RL, Merajver SD, Stoffel EM, Reichert ZR, Morgan TM. Satisfaction With Clinician-Led Germline Genetic Counseling in Patients With Prostate Cancer. J Urol. 2022 Nov;208(5):1007-1017. doi: 10.1097/JU.0000000000002865. Epub 2022 Aug 5. PMID: 35930793.

McCain LA, Milliron KJ, Cook AM, Paquette R, Parvaz JB, Ernst SD, Kittendorf AL, Harper DM, Zazove P, Arthurs J, Tippie JA, Hulswit B, Schroeder LF, Keren DF, Merajver SD. Implementation of INHERET, an Online Family History and Cancer Risk Interpretation Program for Primary Care and Specialty Clinics. J Natl Compr Canc Netw. 2022 Jan;20(1):63-70. doi: 10.6004/jnccn.2021.7072. PMID: 34991067.

2021

Phadke S, Lopez-Barcons L, Vandecan N, Wu Z, Johnson TK, Lachacz EJ, Merajver SD, Soellner MB. Insights into the modular design of kinase inhibitors and application to Abl and Axl. RSC Med Chem. 2021 Nov 5;13(1):64-71. doi: 10.1039/d1md00296a. PMID: 35224497; PMCID: PMC8792823.

Pedrazzani C, Ming C, Bürki N, Caiata-Zufferey M, Chappuis PO, Duquette D, Heinimann K, Heinzelmann-Schwarz V, Graffeo-Galbiati R, Merajver SD, Milliron KJ, Monnerat C, Pagani O, Rabaglio M, Katapodi MC on behalf of the CASCADE Consortium. Genetic Literacy and Communication of Genetic Information in Families Concerned with Hereditary Breast and Ovarian Cancer: A Cross-Study Comparison in Two Countries and within a Timeframe of More than 10 Years. Cancers. 2021; 13(24):6254. https://doi.org/10.3390/cancers13246254.

Sessine MS, Das S, Park B, Salami SS, Kaffenberger SD, Kasputis A, Solorzano M, Luke M, Vince RA, Kaye DR, Borza T, Stoffel EM, Cobain E, Merajver SD, Jacobs MF, Milliron KJ, Caba L, van Neste L, Mondul AM, Morgan TM. Initial Findings from a High Genetic Risk Prostate Cancer Clinic. Urology. 2021 Oct;156:96-103. doi: 10.1016/j.urology.2021.05.078. Epub 2021 Jul 17. PMID: 34280438.

Alghamri MS, McClellan BL, Avvari RP, Thalla R, Carney S, Hartlage MS, Haase S, Ventosa M, Taher A, Kamran N, Zhang L, Faisal SM, Núñez FJ, Garcia-Fabiani MB, Al-Holou WN, Orringer D, Hervey-Jumper S, Heth J, Patil PG, Eddy K, Merajver SD, Ulintz PJ, Welch J, Gao C, Liu J, Núñez G, Hambardzumyan D, Lowenstein PR, Castro MG. G-CSF secreted by mutant IDH1 glioma stem cells abolishes myeloid cell immunosuppression and enhances the efficacy of immunotherapy. Sci Adv. 2021 Oct;7(40):eabh3243. doi: 10.1126/sciadv.abh3243. Epub 2021 Sep 29. PMID: 34586841; PMCID: PMC8480930.

Abraham HG, Ulintz PJ, Goo L, Yates JA, Little AC, Bao L, Wu Z, Merajver SD. RhoC Modulates Cell Junctions and Type I Interferon Response in Aggressive Breast Cancers. Front Oncol. 2021 Aug 26;11:712041. doi: 10.3389/fonc.2021.712041. PMID: 34513691; PMCID: PMC8428533.

Larouche JA, Mohiuddin M, Choi JJ, Ulintz PJ, Fraczek P, Sabin K, Pitchiaya S, Kurpiers SJ, Castor-Macias J, Liu W, Hastings RL, Brown LA, Markworth JF, De Silva K, Levi B, Merajver SD, Valdez G, Chakkalakal JV, Jang YC, Brooks SV, Aguilar CA. Murine muscle stem cell response to perturbations of the neuromuscular junction are attenuated with aging. Elife. 2021 Jul 29;10:e66749. doi: 10.7554/eLife.66749. PMID: 34323217; PMCID: PMC8360658.

Garlick JM, Sturlis SM, Bruno PA, Yates JA, Peiffer AL, Liu Y, Goo L, Bao L, De Salle SN, Tamayo-Castillo G, Brooks CL 3rd, Merajver SD, Mapp AK. Norstictic Acid Is a Selective Allosteric Transcriptional Regulator. J Am Chem Soc. 2021 Jun 30;143(25):9297-9302. doi: 10.1021/jacs.1c03258. Epub 2021 Jun 17. PMID: 34137598. 

McInnis MG, Thompson SB, Merajver SD, Schneider CE. Suicide prevention and mood disorders: Self-exclusion agreements for firearms as a suicide prevention strategy. Asia Pac Psychiatry. 2021 Sep;13(3):e12455. doi: 10.1111/appy.12455. Epub 2021 Mar 8. PMID: 33686800; PMCID: PMC8459244.

Jiagge EM, Ulintz PJ, Wong S, McDermott SP, Fossi SI, Suhan TK, Hoenerhoff MJ, Bensenhaver JM, Salem B, Dziubinski M, Oppong JK, Aitpillah F, Ishmael K, Osei-Bonsu E, Adjei E, Baffour A, Aldrich J, Kurdoglu A, Fernando K, Craig DW, Trent JM, Li J, Chitale D, Newman LA, Carpten JD, Wicha MS, Merajver SD. Multiethnic PDX models predict a possible immune signature associated with TNBC of African ancestry. Breast Cancer Res Treat. 2021 Apr;186(2):391-401. doi: 10.1007/s10549-021-06097-8. Epub 2021 Feb 12. PMID: 33576900. 

Lloyd JP, Soellner MB, Merajver SD, Li JZ. Impact of between-tissue differences on pan-cancer predictions of drug sensitivity. PLoS Comput Biol. 2021 Feb 25;17(2):e1008720. doi: 10.1371/journal.pcbi.1008720. PMID: 33630864; PMCID: PMC7906305. 

Daly MB, Pal T, Berry MP, Buys SS, Dickson P, Domchek SM, Elkhanany A, Friedman S, Goggins M, Hutton ML; CGC; Karlan BY, Khan S, Klein C, Kohlmann W; CGC; Kurian AW, Laronga C, Litton JK, Mak JS; LCGC; Menendez CS, Merajver SD, Norquist BS, Offit K, Pederson HJ, Reiser G; CGC; Senter-Jamieson L; CGC; Shannon KM, Shatsky R, Visvanathan K, Weitzel JN, Wick MJ, Wisinski KB, Yurgelun MB, Darlow SD, Dwyer MA. Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021 Jan 6;19(1):77-102. doi: 10.6004/jnccn.2021.0001. PMID: 33406487.

2020

Yang BA, Westerhof TM, Sabin K, Merajver SD, Aguilar CA. Engineered Tools to Study Intercellular Communication. Adv Sci (Weinh). 2020 Dec 21;8(3):2002825. doi: 10.1002/advs.202002825. PMID: 33552865; PMCID: PMC7856891.

Merrill NM, Vandecan NM, Day KC, Palmbos PL, Day ML, Udager AM, Merajver SD, Soellner MB. MEK is a promising target in the basal subtype of bladder cancer. Oncotarget. 2020 Nov 3;11(44):3921-3932. doi: 10.18632/oncotarget.27767. PMID: 33216841; PMCID: PMC7646827. 

Bhatia S, Palomares MR, Hageman L, Chen Y, Landier W, Smith K, Umphrey H, Reich CA, Zamora KW, Armenian SH, Bevers TB, Blaes A, Henderson T, Hodgson D, Hudson MM, Korde LA, Melin SA, Merajver SD, Overholser L, Pruthi S, Wong FL, Garber JE. A Randomized Phase IIb Study of Low-dose Tamoxifen in Chest-irradiated Cancer Survivors at Risk for Breast Cancer. Clin Cancer Res. 2021 Feb 15;27(4):967-974. doi: 10.1158/1078-0432.CCR-20-3609. Epub 2020 Dec 3. PMID: 33272980; PMCID: PMC7887034.

Yang BA, Westerhof TM, Sabin K, Merajver SD, Aguilar CA. Engineered Tools to Study Intercellular Communication. Adv. Sci. 2020, 2002825. https://doi.org/10.1002/advs.202002825.

Oliver CR, Little AC, Westerhof TM, Pathanjeli P, Yates JA, Merajver SD. Development of an Enhanced-Throughput Radial Cell Migration Device. SLAS Technol. 2021 Apr;26(2):200-208. doi: 10.1177/2472630320971217. Epub 2020 Nov 12. PMID: 33183152; PMCID: PMC7987888.

Abraham HG, Xia Y, Mukherjee B, Merajver SD. Incidence and survival of inflammatory breast cancer between 1973 and 2015 in the SEER database. Breast Cancer Res Treat. 2021 Jan;185(1):229-238. doi: 10.1007/s10549-020-05938-2. Epub 2020 Oct 8. PMID: 33033965. 

Schairer C, Hablas A, Eldein IAS, Gaafar R, Rais H, Mezlini A, Ayed FB, Ayoub WB, Benider A, Tahri A, Khouchani M, Aboulazm D, Karkouri M, Eissa S, Bastawisy AE, Yehia M, Gadalla SM, Swain SM, Merajver SD, Brown LM, Pfeiffer RM, Soliman AS. Risk factors for inflammatory and non-inflammatory breast cancer in North Africa. Breast Cancer Res Treat. 2020 Nov;184(2):543-558. doi: 10.1007/s10549-020-05864-3. Epub 2020 Sep 2. PMID: 32876910. 

Katapodi MC, Ming C, Northouse LL, Duffy SA, Duquette D, Mendelsohn-Victor KE, Milliron KJ, Merajver SD, Dinov ID, Janz NK: Genetic Testing and Surveillance of Young Breast Cancer Survivors and Blood Relatives: A Cluster Randomized Trial. Cancers (Basel) 2020 Sep 5;12(9):E2526. doi: 10.3390/cancers12092526. PMID: 32899538. 

Oliver CR, Westerhof TM, Castro MG, Merajver SD.  Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography. J Vis Exp. (162) 2020 August 16. doi: 10.3791/61654. PMID: 32865534 https://www.jove.com/v/61654/quantifying-brain-metastatic-tumor-micro-environment-using-an-organ.

Liao Y, Gose JW, Arruda EM, Liu AP, Merajver SD, Young YL.  Shock wave impact on the viability of MDA-MB-231 cells. PLoS One. 2020 June 4. doi.org/10.1371/journal.pone.0234138. PMID: 32497154.

Little AC, Kovalenko I, Goo LE, Hong HS, Kerk SA, Yates JA, Purohit V, Lombard DB, Merajver SD, Lyssiotis CA.  Integration of high-content fluorescence imaging into the metabolic flux assay reveals insights into mitochondrial properties and functions. Communications Biology. 2020 May 29. doi: https://doi.org/10.1101/758110. PMID: 32472013. 

Daly MB, Pilarski R, Yurgelun MB, Berry MP, Buys SS, Dickson P, Domchek SM, Elkhanany A, Friedman S, Garber JE, Goggins M, Hutton ML, Khan S, Klein C, Kohlmann W, Kurian AW, Laronga C, Litton JK, Mak JS, Menendez CS, Merajver SD, Norquist BS, Offit K, Pal T, Pederson HJ, Reiser G, Shannon KM, Visvanathan K, Weitzel JN, Wick MJ, Wisinski KB, Dwyer MA, Darlow SD.  NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.  J Natl Compr Canc Netw 2020 April;18(4):380-391. doi: 10.6004/jnccn.2020.0017. PMID: 32259785.

Aw Yong KM, Ulintz PJ, Caceres S, Cheng X, Bao L, Wu Z, Jiagge EM, Merajver SD.  Heterogeneity at the invasion of triple negative breast cancer cells.  Sci Rep.  2020 April 1. doi: 10.1038/s41598-020-62516-8. PMID: 32238832. 

Kaplan MH, Contreras-Galindo R, Jiagge E, Merajver SD, Newman L, Bigman G, Dosik MH, Palapattu GS, Siddiqui J, Chinnaiyan AM, Adebamowo S, Adebamowo C.  Is the HERV-K HML-2 Xq21.33, an endogenous retrovirus mutated by gene conversion of chromosome X in a subset of African populations, associated with human breast cancer?  Infect Agent Cancer.  2020 March 7; 15:19. doi: 10.1186/s13027-020-00284-w. PMID: 32165916.

Chandler BC, Moubadder L, Ritter CL, Liu M, Cameron M, Wilder-Romans K, Zhang A, Pesch AM, Michmerhuizen AR, Hirsh N, Androsiglio M, Ward T, Olsen E, Niknafs YS, Merajver SD, Thomas DG, Brown PH, Lawrence TS, Nyati S, Pierce LJ, Chinnaiyan A, Speers C.  TKK inhibition radiosensitizes basal-like breast cancer through impaired homologous.  J Clin Inves. 2020 Jan 21.  pii: 130435. doi: 10.1172/JCI130435. PMID: 31961339. 

Merrill NM, Lachacz EJ, Vandecan NM, Ulintz PJ, Bao L, Lloyd JP, Yates JA, Morikawa A, Merajver SD, Soellner MB.  Molecular determinants of drug response in TNBC cell lines.  Breast Cancer Res Treat.  2020 Jan. doi: 10.1007/s10549-019-05473-9. PMID: 31655920. 

2019

Katapodi MC, Ming C, Northouse LL, Duffy SA, Duquette D, Mendelsohn-Victor KE, Milliron KJ, Merajver SD, Dinov ID, Janz NK. Outcomes of a Cluster Randomized Trial in Young Breast Cancer Survivors and Blood Relatives: Surveillance and Genetic Services. Preprints 2019, 2019090065. 

Newman LA, Jenkins B, Chen Y, Oppong JK, Adjei E, Jibril AS, Hoda S, Cheng E, Chitale D, Bensenhaver JM, Awuah B, Bekele M, Abebe E, Kyei I, Aitpillah F, Adinku M, Nathanson SD, Jackson L, Jiagge E, Merajver SD, Petersen LF, Proctor E, Gyan KK, Martini R, Kittles R, Davis MB.  Hereditary Susceptibility for Triple Negative Breast Cancer Associated with Western Sub-Saharan African Ancestry:  Results from an International Surgical Breast Cancer Collaborative.  Ann Surg. 2019 Sep;270(3):484-492. doi: 10.1097/SLA. PMID: 31356281. 

Altemus MA, Goo LE, Little AC, Yates JA, Cheriyan HG, Wu ZF, Merjaver SD.  Breast cancers utilize hypoxic glycogen stores via PYGB, the brain isoform of glycogen phosphorylase, to promote metastatic phenotypes.  PLoS One. 2019 Sept 19; 14(9):e0220973. doi: 10.1371/journal.pone.0220973. PMID: 31536495. 

Little AC, Pathanjeli P, Wu Z, Bao L, Goo LE, Yates JA, Oliver CR, Soellner MB, Merajver SD.   IL-4/IL-13 Stimulated Macrophages Enhance Breast Cancer Invasion Via Rho-GTPase Regulation of Synergistic VEGF/CCL-18 Signaling. Front. Oncol. 2019 May 31; 9:456. doi: 10.3389/fonc.2019.00456.  PMID: 31214501. 

Schairer C, Hablas A, Eldein IAS, Gaafar R, Rais H, Mezlini A, Ayed FB, Ayoub WB, Benider A, Tahri A, Khouchani M, Aboulazm D, Karkouri M, Eissa S, Pfeiffer RM, Gadalla SM, Swain SM, Merajver SD, Brown LM, Soliman AS. Clinico-pathologic and mammographic characteristics of inflammatory and non-inflammatory breast cancer at six centers in North Africa. Breast Cancer Res Treat. 2019 Jul;176(2):407-417. doi: 10.1007/s10549-019-05237-5. Epub 2019 Apr 22. PMID: 31006821.

Oliver CR, Altemus MA, Westerhof TM, Cheriyan H, Cheng X, Dziubinski M, Wu Z, Yates J, Morikawa A, Heth J, Castro MG, Leung BM, Takayama S, Merajver SD.  A platform for artificial intelligence based identification of the extravasation potential of cancer cells into the brain metastatic niche. Lab Chip. 2019 Mar 27;19(7):1162-1173. doi: 10.1039/c8lc01387j. PMID: 30810557.

Chen W, Allen SG, Qian W, Peng Z, Han S, Li X, Sun Y, Fournier C, Bao L, Lam RHW, Merajver SD, Fu J.  Biophysical Phenotyping and Modulation of ALDH+ Inflammatory Breast Cancer Stem-Like Cells.  Small, 2019 February, doi: 10.1002/smll.201802891.  PMID: 30632269.

Merz L, Afriyie O, Jiagge E, Adjei E, Foltin SK, Ludwig ML, McHugh JB, Brenner JC, Merajver SD.  Clinical characteristics, HIV status, and molecular biomarkers in squamous cell carcinoma of the conjunctiva in Ghana.  Health Science Report, 2019 January,  doi: 10.1002/hsr2.108.  PMID: 30809594. 

2018

Owusu-Afriyie O, Owiredu WKBA, Owusu-Danquah K, Komarck C, Foltin SK, Larsen-Reindorf R, Acheampong E, Quayson SE, Prince ME, McHugh JB, Donkor P, Merajver SD, Brenner JC. Correction:  Expression of immunohistochemical markers in non-oropharyngeal head and neck squamous cell carcinoma in Ghana.  PLoS One, 2018 December, doi: 10.1371/journal.pone.0209696.  PMID: 30566529.

Kaushal N, Tiruchinapally G, Durmaz YY, Bao L, Gilani R, Merajver SD, ElSayed MEH.  Synergistic inhibition of aggressive breast cancer cell migration and invasion by cytoplasmic delivery of anti-RhoC silencing RNA and presentation of EPPT1 peptide on “smart” particles.  J Control Release, 2018 November, doi: 10.1016/j.jconrel.2018.07.042.  PMID: 30149048.

Nikolaidis C, Duquette D, Mendelsohn-Victor KE, Anderson B, Copeland G, Milliron KJ, Merajver SD, Janz NK, Northouse LL, Duffy SA, Katapodi MC.  Disparities in genetic services utilization in a random sample of young breast cancer survivors.  Genet Med, 2018 November, doi: 10.1038/s41436-018-0349-1. PMID: 30385886.

Jiagge E, Jibril AS, Davis M, Murga-Zamalloa C, Kleer CG, Gyan K, Divine G, Hoenerhoff M, Bensenhave J, Awuah B, Oppong J, Adjei E, Salem B, Toy K, Merajver SD, Wicha M, Newmann L. Androgen receptor and ALDH1 expression among internationally-diverse patient populations.  J Glob Oncol, 2018 October, doi: 10.1200/JGO.18.00056. PMID: 30307804.

Luo M, Shang L, Brooks MD, Jiagge E, Zhu Y, Buschhaus JM, Conley S, Fath MA, Davis A, Gheordunescu E, Wang Y, Harouaka R, Lozier A, Triner D, McDermott S, Merajver SD, Luker GD, Spitz DR, Wicha MS. Targeting Breast Cancer Stem Cell State Equilibrium through Modulation of Redox Signaling. Cell Metab. 2018 Jul 3;28(1):69-86.e6. doi: 10.1016/j.cmet.2018.06.006.

Ko KP, Kim SJ, Huzarski T, Gronwald J, Lubinski J, Lynch HT, Armel S, Park SK, Karlan B, Singer CF, Neuhausen SL, Narod SA, Kotsopoulos J; Hereditary Breast Cancer Clinical Study Group. The association between smoking and cancer incidence in BRCA1 and BRCA2 mutation carriers. Int J Cancer. 2018 Jun 1;142(11):2263-2272. doi: 10.1002/ijc.31257. Epub 2018 Jan 25.

Jones T, Duquette D, Underhill M, Ming C, Mendelsohn-Victor KE, Anderson B, Milliron KJ, Copeland G, Janz NK, Northouse LL, Duffy SM, Merajver SD, Katapodi MC. Surveillance for cancer recurrence in long-term young breast cancer survivors randomly selected from a statewide cancer registry. Breast Cancer Res Treat. 2018 May;169(1):141-152. doi: 10.1007/s10549-018-4674-5. Epub 2018 Jan 20.

Rosselli-Murai LK, Yates JA, Yoshida S, Bourg K, Ho KKY, White M, Prisby J, Tan X, Altemus M, Bao L, Wu Z-F, Veatch SL, Swanson JA, Merajver SD, Liu AP. Loss of PTEN Promotes Formation of Signaling-Capable Clathrin-Coated Pits. J Cell Sci. 2018 Apr 26;131(8). pii: jcs208926. doi: 10.1242/jcs.208926.

Katapodi MC, Jung M, Schafenacker AM, Milliron KJ, Mendelsohn-Victor KE, Merajver SD, Northouse LL. Development of a Web-based Family Intervention for BRCA Carriers and Their Biological Relatives: Acceptability, Feasibility, and Usability Study. JMIR Cancer. 2018 Apr 13;4(1):e7. doi: 10.2196/cancer.9210.

Hadgu E, Seifu D, Tigneh W, Bokretsion Y, Bekele A, Abebe M, Sollie T, Merajver SD, Karlsson C, Karlsson MG. Breast cancer in Ethiopia: evidence for geographic difference in the distribution of molecular subtypes in Africa. BMC Womens Health. 2018 Feb 14;18(1):40. doi: 10.1186/s12905-018-0531-2.